Biosyntia: Funding, Investors & Team (Sep 2026)
Biosyntia is a biotech startup inside manufactured science and metabolic designing. We foster biocatalysts at an uncommon speed and productivity by utilizing our patent forthcoming high-throughput screening innovation. By creating customized processes in view of biocatalysis, Biosyntia empowers creation of complicated synthetic mixtures by maturation. Biocatalysis may considerably lessen both creation costs and natural effect contrasted with different cycles like substance blend. We cooperate with producers of fine substance compounds (flavors, scents, APIs, colors, added substances, intermediates, and the sky is the limit from there) to lay out more manageable assembling processes for a greener tomorrow. Biosyntia is situated at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
Biosyntia has raised $11.7M across 1 funding round on record, the most recent a Series B of $11.7M announced in Jul 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biosyntia Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Biosyntia Funding Rounds
Biosyntia Founders and Leadership Team
No contact details are on record for this team yet.
Biosyntia Funding Compared to Other Biotechnology Startups
Biosyntia's latest round of $11.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biosyntia in Biotechnology and Hørsholm
Companies Similar to Biosyntia
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
Biosyntia Funding FAQs
What does Biosyntia do?
Biosyntia is a biotech startup inside manufactured science and metabolic designing. We foster biocatalysts at an uncommon speed and productivity by utilizing our patent forthcoming high-throughput screening innovation. By creating customized processes in view of biocatalysis, Biosyntia empowers creation of complicated synthetic mixtures by maturation. Biocatalysis may considerably lessen both creation costs and natural effect contrasted with different cycles like substance blend. We cooperate with producers of fine substance compounds (flavors, scents, APIs, colors, added substances, intermediates, and the sky is the limit from there) to lay out more manageable assembling processes for a greener tomorrow. Biosyntia is situated at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
How much funding has Biosyntia raised?
Biosyntia has raised $11.7M across 1 round on record. The most recent is a Series B of $11.7M announced in Jul 2022.
When did Biosyntia last raise funding?
Biosyntia's most recent funding round on record is a Series B of $11.7M, announced in Jul 2022.
Who founded Biosyntia?
FundedIQ lists Hans Genee (Founder) at Biosyntia.
Where is Biosyntia headquartered?
Biosyntia is based in Hørsholm, Hovedstaden, Denmark.
How many employees does Biosyntia have?
Biosyntia is in the 11-50 employee band.
How does Biosyntia's funding compare to other Biotechnology startups?
Biosyntia's latest round of $11.7M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Biosyntia Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biosyntia is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.